Mariner’s Zymeworks ZYME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-162,550
Closed -$1.03M 3190
2023
Q3
$1.03M Sell
162,550
-141,300
-47% -$1.04M ﹤0.01% 1302
2023
Q2
$2.63M Sell
303,850
-17,850
-6% -$160K 0.01% 872
2023
Q1
$2.91M Sell
321,700
-35,950
-10% -$314K 0.01% 814
2022
Q4
$2.81M Buy
+357,650
New +$2.51M 0.01% 787

Other funds holding ZYME

Mariner's ZYME Position: Q4 2023 in Review

Mariner sold out of Zymeworks (ZYME) in Q4 2023, closing a stake of 162,550 shares — an estimated $1.03M sold.

Mariner first reported a position in ZYME in Q4 2022 and held it in 4 quarters. The position peaked at $2.91M in Q1 2023. 157 funds tracked by Wall St. Rank hold ZYME as of Q4 2023.

  • Mariner reported no remaining Zymeworks position as of Q4 2023 after selling out during the quarter.
  • Mariner sold 162,550 Zymeworks shares in Q4 2023, an estimated $1.03M.
  • Mariner first reported a position in Zymeworks in Q4 2022 and held it in 4 quarters.
  • Mariner's Zymeworks position peaked at $2.91M in Q1 2023.
  • 157 funds tracked by Wall St. Rank held Zymeworks as of Q4 2023.

Based on Mariner's 13F filing for Q4 2023, filed 14 Feb 2024.